These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25514603)

  • 1. Chemically synthesized molecules with the targeting and effector functions of antibodies.
    McEnaney PJ; Fitzgerald KJ; Zhang AX; Douglass EF; Shan W; Balog A; Kolesnikova MD; Spiegel DA
    J Am Chem Soc; 2014 Dec; 136(52):18034-43. PubMed ID: 25514603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands.
    Subedi M; Minn I; Chen J; Kim Y; Ok K; Jung YW; Pomper MG; Byun Y
    Eur J Med Chem; 2016 Aug; 118():208-218. PubMed ID: 27128184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fc-Binding Antibody-Recruiting Molecules Targeting Prostate-Specific Membrane Antigen: Defucosylation of Antibody for Efficacy Improvement*.
    Sasaki K; Harada M; Yoshikawa T; Tagawa H; Harada Y; Yonemitsu Y; Ryujin T; Kishimura A; Mori T; Katayama Y
    Chembiochem; 2021 Feb; 22(3):496-500. PubMed ID: 32969164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA.
    Ivanenkov YA; Machulkin AE; Garanina AS; Skvortsov DA; Uspenskaya AA; Deyneka EV; Trofimenko AV; Beloglazkina EK; Zyk NV; Koteliansky VE; Bezrukov DS; Aladinskaya AV; Vorobyeva NS; Puchinina MM; Riabykh GK; Sofronova AA; Malyshev AS; Majouga AG
    Bioorg Med Chem Lett; 2019 May; 29(10):1246-1255. PubMed ID: 30904185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based drug design, synthesis, In vitro, and In vivo biological evaluation of indole-based biomimetic analogs targeting estrogen receptor-α inhibition.
    Hendy MS; Ali AA; Ahmed L; Hossam R; Mostafa A; Elmazar MM; Naguib BH; Attia YM; Ahmed MS
    Eur J Med Chem; 2019 Mar; 166():281-290. PubMed ID: 30731397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential effective inhibitory compounds against Prostate Specific Membrane Antigen (PSMA): A molecular docking and molecular dynamics study.
    Nikfarjam Z; Bavi O; Amini SK
    Arch Biochem Biophys; 2021 Mar; 699():108747. PubMed ID: 33422503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.
    Bandari RP; Jiang Z; Reynolds TS; Bernskoetter NE; Szczodroski AF; Bassuner KJ; Kirkpatrick DL; Rold TL; Sieckman GL; Hoffman TJ; Connors JP; Smith CJ
    Nucl Med Biol; 2014 Apr; 41(4):355-63. PubMed ID: 24508213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of highly potent urea-based, exosite-binding inhibitors selective for glutamate carboxypeptidase II.
    Tykvart J; Schimer J; Jančařík A; Bařinková J; Navrátil V; Starková J; Šrámková K; Konvalinka J; Majer P; Šácha P
    J Med Chem; 2015 May; 58(10):4357-63. PubMed ID: 25923815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase.
    Davis MI; Bennett MJ; Thomas LM; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):5981-6. PubMed ID: 15837926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer.
    Harada N; Kimura H; Onoe S; Watanabe H; Matsuoka D; Arimitsu K; Ono M; Saji H
    J Nucl Med; 2016 Dec; 57(12):1978-1984. PubMed ID: 27417647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye-Protein Interaction.
    Hensbergen AW; Buckle T; van Willigen DM; Schottelius M; Welling MM; van der Wijk FA; Maurer T; van der Poel HG; van der Pluijm G; van Weerden WM; Wester HJ; van Leeuwen FWB
    J Nucl Med; 2020 Feb; 61(2):234-241. PubMed ID: 31481575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudoirreversible inhibition of prostate-specific membrane antigen by phosphoramidate peptidomimetics.
    Liu T; Toriyabe Y; Kazak M; Berkman CE
    Biochemistry; 2008 Dec; 47(48):12658-60. PubMed ID: 18983168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and
    Cordonnier A; Boyer D; Besse S; Valleix R; Mahiou R; Quintana M; Briat A; Benbakkar M; Penault-Llorca F; Maisonial-Besset A; Maunit B; Tarrit S; Vivier M; Witkowski T; Mazuel L; Degoul F; Miot-Noirault E; Chezal JM
    J Mater Chem B; 2021 Sep; 9(36):7423-7434. PubMed ID: 34373887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tight nanoscale clustering of Fcγ receptors using DNA origami promotes phagocytosis.
    Kern N; Dong R; Douglas SM; Vale RD; Morrissey MA
    Elife; 2021 Jun; 10():. PubMed ID: 34080973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigen.
    Lupold SE; Rodriguez R
    Mol Cancer Ther; 2004 May; 3(5):597-603. PubMed ID: 15141017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells.
    Bakht MK; Hayward JJ; Shahbazi-Raz F; Skubal M; Tamura R; Stringer KF; Meister D; Venkadakrishnan VB; Xue H; Pillon A; Stover M; Tronchin A; Fifield BA; Mader L; Ku SY; Cheon GJ; Kang KW; Wang Y; Dong X; Beltran H; Grimm J; Porter LA; Trant JF
    Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35064078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent Immune Recruiters: Tools to Gain Chemical Control Over Immune Recognition.
    Lake B; Serniuck N; Kapcan E; Wang A; Rullo AF
    ACS Chem Biol; 2020 Apr; 15(4):1089-1095. PubMed ID: 32100991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of a novel BODIPY-labeled PSMA inhibitor.
    Son SH; Kwon H; Ahn HH; Nam H; Kim K; Nam S; Choi D; Ha H; Minn I; Byun Y
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126894. PubMed ID: 31874825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bispecific radioligands targeting prostate-specific membrane antigen and gastrin-releasing peptide receptors on the surface of prostate cancer cells.
    Liolios C; Sachpekidis C; Schäfer M; Kopka K
    J Labelled Comp Radiopharm; 2019 Jun; 62(8):510-522. PubMed ID: 31070273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-resolution structure of ligand-free human glutamate carboxypeptidase II.
    Barinka C; Starkova J; Konvalinka J; Lubkowski J
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Mar; 63(Pt 3):150-3. PubMed ID: 17329803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.